RESANZ
DEAD

Serial Number

87139640

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 16, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RESANZ Trademark

Serial Number: 87139640

RESANZ is a trademark filed by NOVARTIS AG on August 16, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 16, 2016

Registration Date

Not Registered

Published for Opposition

June 6, 2017

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 8, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 7, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2020 EXRA
SOU EXTENSION 5 GRANTED
Feb 4, 2020 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 4, 2020 AITU
SOU EXTENSION 5 FILED
Jan 31, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 31, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jul 31, 2019 EX4G
SOU EXTENSION 4 FILED
Jul 31, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 31, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2019 EXRA
SOU EXTENSION 3 GRANTED
Jan 30, 2019 EX3G
SOU EXTENSION 3 FILED
Jan 30, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 30, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2018 EXRA
SOU EXTENSION 2 GRANTED
Jul 31, 2018 EX2G
SOU EXTENSION 2 FILED
Jul 31, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 31, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jan 31, 2018 EX1G
SOU EXTENSION 1 FILED
Jan 31, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 31, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 4, 2017 PREV
ASSIGNED TO LIE
Apr 26, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2017 CRFA
ASSIGNED TO LIE
Apr 6, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2016 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2016 NWOS
NEW APPLICATION ENTERED
Aug 19, 2016 NWAP